UBS Asset Management Americas Inc. Raises Stake in Stryker Corporation (SYK)

UBS Asset Management Americas Inc. boosted its stake in shares of Stryker Corporation (NYSE:SYK) by 7.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,099,672 shares of the medical technology company’s stock after purchasing an additional 73,074 shares during the quarter. UBS Asset Management Americas Inc. owned about 0.29% of Stryker Corporation worth $152,612,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in SYK. Acrospire Investment Management LLC acquired a new stake in shares of Stryker Corporation during the second quarter worth $111,000. Bollard Group LLC lifted its holdings in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares in the last quarter. Motco lifted its holdings in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares in the last quarter. Bruderman Asset Management LLC acquired a new stake in shares of Stryker Corporation during the second quarter worth $150,000. Finally, James Investment Research Inc. acquired a new stake in shares of Stryker Corporation during the second quarter worth $155,000. 74.13% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “UBS Asset Management Americas Inc. Raises Stake in Stryker Corporation (SYK)” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://ledgergazette.com/2017/10/11/ubs-asset-management-americas-inc-raises-stake-in-stryker-corporation-syk.html.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by insiders.

A number of research firms recently commented on SYK. BidaskClub downgraded Stryker Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Stryker Corporation in a research note on Monday, June 19th. Morgan Stanley boosted their target price on Stryker Corporation from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 21st. Cantor Fitzgerald began coverage on Stryker Corporation in a research note on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price for the company. Finally, Jefferies Group LLC reissued a “hold” rating and set a $132.00 target price on shares of Stryker Corporation in a research note on Friday, June 30th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $146.78.

Stryker Corporation (NYSE SYK) opened at 144.69 on Wednesday. The company has a market capitalization of $54.12 billion, a PE ratio of 32.30 and a beta of 0.80. The firm’s 50 day moving average price is $142.48 and its 200-day moving average price is $140.29. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $149.23.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. Stryker Corporation’s revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.39 EPS. On average, equities analysts anticipate that Stryker Corporation will post $6.45 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.17%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is currently 37.95%.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medica

A number of other hedge funds also recently added to or reduced their stakes in SYK. Acrospire Investment Management LLC acquired a new stake in shares of Stryker Corporation during the second quarter worth $111,000. Bollard Group LLC lifted its holdings in shares of Stryker Corporation by 0.4% during the second quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after buying an additional 3 shares in the last quarter. Motco lifted its holdings in shares of Stryker Corporation by 50.7% during the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares in the last quarter. Bruderman Asset Management LLC acquired a new stake in shares of Stryker Corporation during the second quarter worth $150,000. Finally, James Investment Research Inc. acquired a new stake in shares of Stryker Corporation during the second quarter worth $155,000. 74.13% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “UBS Asset Management Americas Inc. Raises Stake in Stryker Corporation (SYK)” was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this piece of content can be read at https://ledgergazette.com/2017/10/11/ubs-asset-management-americas-inc-raises-stake-in-stryker-corporation-syk.html.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction that occurred on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total value of $164,396.24. Following the completion of the sale, the insider now directly owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. 7.40% of the stock is currently owned by insiders.

A number of research firms recently commented on SYK. BidaskClub downgraded Stryker Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Stryker Corporation in a research note on Monday, June 19th. Morgan Stanley boosted their target price on Stryker Corporation from $145.00 to $155.00 and gave the stock an “overweight” rating in a research note on Wednesday, June 21st. Cantor Fitzgerald began coverage on Stryker Corporation in a research note on Thursday, June 29th. They set a “neutral” rating and a $153.00 target price for the company. Finally, Jefferies Group LLC reissued a “hold” rating and set a $132.00 target price on shares of Stryker Corporation in a research note on Friday, June 30th. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $146.78.

Stryker Corporation (NYSE SYK) opened at 144.69 on Wednesday. The company has a market capitalization of $54.12 billion, a PE ratio of 32.30 and a beta of 0.80. The firm’s 50 day moving average price is $142.48 and its 200-day moving average price is $140.29. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $149.23.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. Stryker Corporation’s revenue was up 6.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.39 EPS. On average, equities analysts anticipate that Stryker Corporation will post $6.45 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.17%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is currently 37.95%.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply